The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression
Open accessAbstract
Noncoding RNAs play important roles in cancer biology, providing potential targets for cancer intervention. As a new class of endogenous noncoding RNAs, circular RNAs (circRNAs) have been recently identified in cell development and function, and certain types of pathological responses, generally acting as a microRNA (miRNA) sponge to regulate gene expression. Identifying the deregulated circRNAs and their roles in cancer has attracted much attention. However, the expression profile and function of circRNAs in human hepatocellular carcinoma (HCC) remain to be investigated. Here, we analyzed the expression profile of human circRNAs in HCC tissues and identified circMTO1 (mitochondrial translation optimization 1 homologue; hsa_circRNA_0007874/hsa_circRNA_104135) as one circRNA significantly down‐regulated in HCC tissues. HCC patients with low circMTO1 expression had shortened survival. By using a biotin‐labeled circMTO1 probe to perform RNA in vivo precipitation in HCC cells, we identified miR‐9 as the circMTO1‐associated miRNA. Furthermore, silencing of circMTO1 in HCC could down‐regulate p21, the target of oncogenic miR‐9, resulting in the promotion of HCC cell proliferation and invasion. In addition, the tumor‐promoting effect of circMTO1 silencing was blocked by miR9 inhibitor. Intratumoral administration of cholesterol‐conjugated circMTO1 small interfering RNA promoted tumor growth in HCC‐bearing mice in vivo. Conclusion: circMTO1 suppresses HCC progression by acting as the sponge of oncogenic miR‐9 to promote p21 expression, suggesting that circMTO1 is a potential target in HCC treatment. The decrease of circMTO1 in HCC tissues may serve as a prognosis predictor for poor survival of patients. (H epatology 2017;66:1151‐1164).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, L., Li, N., Wang, C., Yu, Y., Yuan, L., Zhang, M., & Cao, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312895200 · Cited by 88
Self-citationRetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Detecting and characterizing circular RNAs
Jeck, W. R., & Sharpless, N. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2890 · Cited by 2,702
Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
Li, Y., Zheng, Q., Bao, C., Li, S., Guo, W., Zhao, J., Chen, D., Gu, J., He, X., & Huang, S. (2015) · Cell Research · doi:10.1038/cr.2015.82 · Cited by 2,204
Regulation of circRNA biogenesis
Chen, L.-L., & Yang, L. (2015) · RNA Biology · doi:10.1080/15476286.2015.1020271 · Cited by 1,953
Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
Du, W. W., Yang, W., Liu, E., Yang, Z., Dhaliwal, P., & Yang, B. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw027 · Cited by 1,699
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Using circular RNA as a novel type of biomarker in the screening of gastric cancer
Li, P., Chen, S., Chen, H., Mo, X., Li, T., Shao, Y., Xiao, B., & Guo, J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.02.018 · Cited by 774
Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., Wang, Z., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900707 · Cited by 739
Self-citationHou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., Dong, Q., Qin, L., Wu, X., Zheng, Y., Yang, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.001 · Cited by 690
Self-citationCircular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway
Li, F., Zhang, L., Li, W., Deng, J., Zheng, J., An, M., Lu, J., & Zhou, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3469 · Cited by 637
Circular RNA (circRNA) in Alzheimer’s disease (AD)
Lukiw, W. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00307 · Cited by 636 · cited 1×
“circRNAs have been recently verified to be involved in developmental processes, regulation of cell function, pathogenesis of heart diseases, and development of neurodegenerative diseases like Alzheimer’s disease.((5)) In the study of carcinogenesis and progression, just like the extensive involvement of miRNAs in canc…”
BackgroundBeuvink, I., Boulay, A., Fumagalli, S., Zilbermann, F., Ruetz, S., O’Reilly, T., Natt, F., Hall, J., Lane, H. A., & Thomas, G. (2005) · Cell · doi:10.1016/j.cell.2004.12.040 · Cited by 486
Circular RNAs: splicing’s enigma variations
Hentze, M. W., & Preiss, T. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.53 · Cited by 455
lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals
Xing, Z., Lin, A., Li, C., Liang, K., Wang, S., Liu, Y., Park, P. K., Qin, L., Wei, Y., Hawke, D. H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.013 · Cited by 447
Yuan, S., Wang, J., Yang, F., Tao, Q., Zhang, J., Wang, L., Yang, Y., Liu, H., Wang, Z., Xu, Q., et al. (2016) · Hepatology · doi:10.1002/hep.27893 · Cited by 404
Self-citationcir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway
Huang, G., Zhu, H., Shi, Y., Wu, W., Cai, H., & Chen, X. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131225 · Cited by 291
Guo, W., Qiu, Z., Wang, Z., Wang, Q., Tan, N., Chen, T., Chen, Z., Huang, S., Gu, J., Li, J., et al. (2015) · Hepatology · doi:10.1002/hep.27929 · Cited by 250
Self-citationZhao, X., Dou, W., He, L., Liang, S., Tie, J., Liu, C., Li, T., Lu, Y., Mo, P., Shi, Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.156 · Cited by 218
microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis
Zhang, N., Li, X., Wu, C. W., Dong, Y., Cai, M., Mok, M. T. S., Wang, H., Chen, J., Ng, S. S. M., Chen, M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.526 · Cited by 212
Self-citationMiR‐9 downregulates CDX2 expression in gastric cancer cells
Rotkrua, P., Akiyama, Y., Hashimoto, Y., Otsubo, T., & Yuasa, Y. (2011) · International Journal of Cancer · doi:10.1002/ijc.25923 · Cited by 135
Chen, P., Price, C. O., Li, Z., Li, Y., Cao, D., Wiley, A., He, C., Gurbuxani, S. K., Kunjamma, R. B., Huang, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310144110 · Cited by 119
Zhang, X., Hu, S., Zhang, X., Wang, L., Zhang, X., Yan, B., Zhao, J., Yang, A., & Zhang, R. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.095 · Cited by 112
Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2
Long, L., Huang, G., Zhu, H., Guo, Y., Liu, Y., & Huo, J. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-275 · Cited by 90
Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome
Wang, C., Huang, X.-F., Cai, Q.-Q., Xx, C., Duan, M.-H., Cai, H., Zhou, D.-B., & Li, J. (2016) · Leukemia · doi:10.1038/leu.2016.168 · Cited by 89
Self-citationSu, X.-P., Wang, H.-M., Ge, W., Yang, M.-J., Hou, J., Chen, T.-Y., Li, N., & Cao, X.-T. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2218 · Cited by 77
Self-citationDrakaki, A., Hatziapostolou, M., Polytarchou, C., Vorvis, C., Poultsides, G. A., Souglakos, J., Georgoulias, V., & Iliopoulos, D. (2015) · BMC Cancer · doi:10.1186/s12885-015-1562-9 · Cited by 70
Zhang, Y., Liu, Y., Duan, J., Yan, H., Zhang, J., Zhang, H., Fan, Q., Luo, F., Yan, G., Qiao, K., et al. (2015) · Hepatology · doi:10.1002/hep.28395 · Cited by 61
Ma, C., Qi, Y., Shao, L., Liu, M., Li, X., & Tang, H. (2013) · IUBMB Life · doi:10.1002/iub.1231 · Cited by 54
Wang, H., Su, X., Yang, M., Chen, T., Hou, J., Li, N., & Cao, X. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1031440 · Cited by 42
Self-citationSmall GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression
Chen, T., Yang, M., Zhou, Y., Tang, S., Wang, C., Zhu, X., Guo, J., Li, N., Zhang, W., Hou, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.009 · Cited by 40
Self-citationZhang, X., Ma, W., Cui, J., Yao, H., Zhou, H., Ge, Y., Xiao, L., Hu, X., Liu, B.-H., Yang, J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.241 · Cited by 33
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer
Zhen, Y., Xinghui, Z., Chao, W., Zhao, Y. C., Jinwen, C., Ruifang, G., Chao, Z., Zhao, M., Guo, C., Yan, F., et al. (2017) · Scientific Reports · doi:10.1038/srep45195 · Cited by 23
Cited by
Circular RNAs in cancer: opportunities and challenges in the field
Kristensen, L. S., Hansen, T. B., Venø, M. T., & Kjems, J. (2018) · Oncogene · doi:10.1038/onc.2017.361 · Cited by 1,326
Circular RNAs Act as miRNA Sponges
Panda, A. C. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-1426-1_6 · Cited by 1,109
Noncoding RNA:RNA Regulatory Networks in Cancer
Chan, J. J., & Tay, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051310 · Cited by 1,033
Circular RNAs function as ceRNAs to regulate and control human cancer progression
Zhong, Y., Du, Y., Yang, X., Mo, Y., Fan, C., Xiong, F., Ren, D., Ye, X., Li, C., Wang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0827-8 · Cited by 1,007
Zhang, X., Wang, S., Wang, H., Cao, J., Huang, X., Chen, Z., Xu, P., Sun, G., Xu, J., Lv, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0935-5 · Cited by 842
Self-citationRetracted
Metadata
- Authors
- Han, D., Li, J., Wang, H., Su, X., Hou, J., Gu, Y., Qian, C., Lin, Y., Liu, X., Huang, M., Li, N., Zhou, W., Yu, Y., & Cao, X.
- Venue
- Hepatology
- Published
- 2017-08-26
- Volume
- 66
- Issue
- 4
- Pages
- 1151-1164
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2616072553
- Cited by
- 1,214
- References
- 39
- FWCI
- 64.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.